At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 13 enrolled
Drug / intervention
Stem Cell Educator Therapybiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
In Brief
A Phase 1 clinical trial evaluating Stem Cell Educator Therapy for Diabetes Mellitus Type 1. Completed, enrolled 13 participants across 1 site.
Detailed Summary
This is a prospective, single arm, open-label, single-center pilot study to assess the safety, feasibility, and efficacy of Stem Cell Educator therapy for the treatment of patients with Type 1 Diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus Type 1
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 2015
Enrollment StartJun 2017
Primary CompletionNov 2022
Study CompletionMar 2024
TodayJul 2026
First PostedDec 8, 2015
Enrollment StartJun 27, 2017
Primary CompletionNov 11, 2022
Study CompletionMar 11, 2024
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 10.6 years ago
Interventions
Stem Cell Educator Therapybiological
Patients will receive apheresis and then have their own blood returned to them with the "educated" lymphocytes